FDA Clears New Hologic Breast, Pelvic, Prostate MRI Coil Arrays

September 28, 2011 – The U.S. Food and Drug Administration (FDA) has cleared two Hologic Sentinelle magnetic resonance imaging (MRI) Solutions products: Sentinelle Endo Coil Array for pelvic imaging including the prostate, cervix, colon and the surrounding tissues in the pelvis, and Sentinelle’s 16 -channel Breast Coil Array for use with Siemens 1.5T and 3.0T MRI systems. Both coils will be featured at Radiology Society of North American (RSNA) 2011.

The Sentinelle breast MRI coil comes in two configurations: an award-winning design patient stretcher with integrated breast MRI coils, and a tabletop configuration leveraging the same open-access features of the patient stretcher. Both patient support configurations provide greater access for patient positioning and intervention, optimal patient comfort and improved workflow.

Hologic's breast MRI solutions are highly sensitive for cancer staging, problem-solving, post treatment surveillance and other indications. Breast MRI can detect many breast cancers that are often hidden when using standard imaging

For more information: www.hologic.com